FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Ranitidine Injection, USP
Status: Currently in Shortage
»Date first posted: 12/08/2016
»Therapeutic Categories: Gastroenterology

Expand all

Mylan Institutional (Reverified 11/26/2019)

Company Contact Information:
800-796-9526

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Ranitidine Injection 25 mg/mL, 2ml vial; 10 pack; (NDC 67457-397-99) Available
Ranitidine Injection 25 mg/mL, 6 mL vial; 1 pack; (NDC 67457-398-62) Available

Teligent Pharma, Inc. (Reverified 10/29/2019)

Company Contact Information:
856-697-1441

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
ZANTAC INJECTABLE 25MG/ML 2ML VIAL (NDC 52565-101-01) Unavailable Demand increase for the drug
ZANTAC INJECTABLE 25MG/ML 40ML VIAL (NDC 52565-096-01) Unavailable Demand increase for the drug
ZANTAC INJECTABLE 25MG/ML 6ML VIAL (NDC 52565-102-01) Unavailable Demand increase for the drug

Zydus Pharmaceuticals USA Inc. (Revised 10/29/2019)

Company Contact Information:
609-730-1900

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Ranitidine HCl Injection 25mg/mL (10x2mL SD vials)(NDC 68382-422-02) Available Other
Ranitidine HCl Injection 25mg/mL (6mL MD vial)(NDC 68382-423-06) Unavailable Other

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English